BioCentury | Feb 25, 2013
Company News

NexGen Medical Systems Inc, Stem Cell Therapeutics deal

...to be finalized within 60 days. ReNeu will receive worldwide, royalty-free licenses to use NexGen's EviTAR...
BioCentury | Aug 13, 2012
Company News

AdeTherapeutics dermatology news

...in the company. AdeTherapeutics develops products to reduce fibrosis or scar tissue complications from surgery. Evitar...
...testing to prevent adhesion formation in gynecological procedures. The company said it plans to partner Evitar...
BioCentury | Dec 5, 2011
Clinical News

Evitar: Phase I start

...to evaluate 1 g/kg intraperitoneal Evitar in 38 patients. AdeTherapeutics Inc. , Saskatoon, Saskatchewan Product: Evitar...
Items per page:
1 - 3 of 3